Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Stanelle

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Annual Review of Pathology|April 30, 2009
Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphomaRoland Schmitz, Jens Stanelle, Martin-Leo Hansmann, et al.
Blood|July 28, 2010
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cellsJens Stanelle, Claudia Döring, Martin-Leo Hansmann, et al.
Nucleic Acids Research|April 9, 2002
Gene expression changes in response to E2F1 activationJens Stanelle, Thorsten Stiewe, Carmen C Theseling, et al.
Molecular Immunology|April 24, 2008
EBV transformation overrides gene expression patterns of B cell differentiation stagesDörte Siemer, Julia Kurth, Stephan Lang, et al.
Cardiovascular Research|August 12, 2003
Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cellsJens Stanelle, Thorsten Stiewe, Florian Rödicker, et al.
The Journal of Biological Chemistry|February 14, 2003
Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73Thorsten Stiewe, Jens Stanelle, Carmen C Theseling, et al.
Blood|September 9, 2006
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaHolger Nückel, Ulrich H Frey, Maja Bau, et al.
Leukemia & Lymphoma|January 7, 2012
p53 protein expression in chronic lymphocytic leukemiaLudger Sellmann, Alexander Carpinteiro, Holger Nückel, et al.
The Journal of Experimental Medicine|April 22, 2009
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaRoland Schmitz, Martin-Leo Hansmann, Verena Bohle, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Annual Review of Pathology|April 30, 2009
Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphomaRoland Schmitz, Jens Stanelle, Martin-Leo Hansmann, et al.
Blood|July 28, 2010
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cellsJens Stanelle, Claudia Döring, Martin-Leo Hansmann, et al.
Nucleic Acids Research|April 9, 2002
Gene expression changes in response to E2F1 activationJens Stanelle, Thorsten Stiewe, Carmen C Theseling, et al.
Molecular Immunology|April 24, 2008
EBV transformation overrides gene expression patterns of B cell differentiation stagesDörte Siemer, Julia Kurth, Stephan Lang, et al.
Cardiovascular Research|August 12, 2003
Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cellsJens Stanelle, Thorsten Stiewe, Florian Rödicker, et al.
The Journal of Biological Chemistry|February 14, 2003
Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73Thorsten Stiewe, Jens Stanelle, Carmen C Theseling, et al.
Blood|September 9, 2006
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaHolger Nückel, Ulrich H Frey, Maja Bau, et al.
Leukemia & Lymphoma|January 7, 2012
p53 protein expression in chronic lymphocytic leukemiaLudger Sellmann, Alexander Carpinteiro, Holger Nückel, et al.
The Journal of Experimental Medicine|April 22, 2009
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaRoland Schmitz, Martin-Leo Hansmann, Verena Bohle, et al.
Pageof 2